HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...

CONVERGE is studying patients with locally advanced non-small cell lung cancer who are receiving chemoradiation followed by ...

NSCLC starts in the lungs, but when it metastasizes, it spreads to other body areas. This cancer may spread to any body part, but commonly the brain, bones, liver, and lymph nodes. Symptoms vary ...

Lung cancer remains the deadliest malignancy worldwide, and non-small cell lung cancer (NSCLC) accounts for roughly 85 ...

A diagnosis of advanced non-small-cell lung cancer (NSCLC) can bring a lot of questions. The FDA approved Jideytro (zidesamtinib) in 2026. It belongs to a group of medicines known as kinase inhibitors ...

Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data, today announced the launch of Breast Cancer and Non-Small Cell Lung ...

A diagnosis of non-small cell lung cancer (NSCLC) can significantly affect emotional health, leading to mental health challenges such as depression, anxiety, and distress. Comprehensive mental health ...

Non-dilutive federal funding will support preclinical and clinical work validating red blood cell-bound tumor DNA as an early ...

ROS1-positive non-small cell lung cancer (NSCLC) is a rare subtype of lung cancer that occurs when part of the ROS1 gene fuses with another gene. It affects about 1% to 2% of people with NSCLC and ...

ROS1-positive non-small cell lung cancer (NSCLC) is a rare lung cancer subtype occurring when part of the ROS1 gene fuses with another gene. Affecting around 1% to 2% of people with NSCLC, it tends to ...